NCT07399652 Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures
| NCT ID | NCT07399652 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asian Institute of Gastroenterology, India |
| Condition | Achalasia Cardia |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-02-10 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective study aims to evaluate the performance of a novel Artificial Intelligence (AI) clinical decision support tool during third space endoscopic procedures, such as Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). While these procedures are effective for treating gastrointestinal neoplasms and motility disorders, they carry risks of intraprocedural bleeding and perforation if submucosal blood vessels are not correctly identified and coagulated. Building on previous retrospective validation, this study will assess whether a real-time artificial intelligence model can assist endoscopists in detecting and delineating blood vessels more accurately and faster during live human procedures.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with Achalasia Cardia or neoplasms. Exclusion Criteria: * Patients with conditions deemed unsuitable for third space endoscopy procedures (e.g.: Candidiasis)
Contact & Investigator
Abhishek Tyagi
PRINCIPAL INVESTIGATOR
Asian Intitute of Gastroenterology
Frequently Asked Questions
Who can join the NCT07399652 clinical trial?
This trial is open to participants of all sexes, studying Achalasia Cardia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07399652 currently recruiting?
Yes, NCT07399652 is actively recruiting participants. Contact the research team at mr.tyagi@gmail.com for enrollment information.
Where is the NCT07399652 trial being conducted?
This trial is being conducted at Hyderabad, India.
Who is sponsoring the NCT07399652 clinical trial?
NCT07399652 is sponsored by Asian Institute of Gastroenterology, India. The principal investigator is Abhishek Tyagi at Asian Intitute of Gastroenterology. The trial plans to enroll 20 participants.